Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ANG Lifesciences India Ltd - 540694 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to above captioned subject, Notice of Postal Ballot is attached herewith to transact the business as set out in the notice of Postal Ballot that is proposed to be passed by the Members of the Company through Remote e-voting. Calendar of Events for Postal Ballot/ E-voting are mentioned in the notice herewith enclosed. Kindly take the same on your record.
03-06-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 & 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing an extract of the Newspaper publications of consolidated & standalone audited financial results for the quarter and financial year ended 31st March, 2022. Kindly take the same on your record.
02-06-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Intimation Of Change In Corporate Office Address Of Registrar And Share Transfer Agent ('RTA') Of The Company.

 This is to inform you that the Registrar & Share Transfer Agent (RTA) of the Company i.e. 'Bigshare Services Private Limited' has shifted its Corporate office. The new address of Bigshare Services Private Limited (RTA) is as under:- Bigshare Services Private Limited Address - Office No S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093. Telephone-022-62638299 Fax-022-62638299 [email protected] Website-www.bigshareonline.com Kindly take the same on your record.
02-06-2022
Bigul

Annual report for ANG Lifesciences India Ltd. for FY-2022
01-06-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Corporate Action-Board recommends Bonus Issue

 The Board of Directors of the Company has considered & recommended the issuance of fully paid up Bonus Shares in proportion of 1:4 i.e. 1(one) fully paid up share for every 4(four) fully paid-up shares held by shareholder of the company, subject to shareholders' approval.
30-05-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Outcome Of Board Meeting

 Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of ANG Lifesciences India Limited at their Meeting held today i.e. Monday, May 30, 2022, at the Registered Office of the Company situated at Darbara Complex, SCO-113, District Shopping Centre, B Block, Ranjit Avenue, Amritsar-143001 transacted the following as per enclosed document.
30-05-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting

 Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of ANG Lifesciences India Limited at their Meeting held today i.e. Monday, May 30, 2022, at the Registered Office of the Company situated at Darbara Complex, SCO-113, District Shopping Centre, B Block, Ranjit Avenue, Amritsar-143001 transacted the following business as per enclosed document.
30-05-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Annual Secretarial Compliance Report of the Company for the year ended March 31, 2022, issued by M/s Anjum Goyal & Associates, Practicing Company Secretaries.
29-05-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Board to consider Bonus Issue

 ANG Lifesciences India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled tobe held on May 30, 2022, inter alia, transact the following business:1. To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2022.2. To consider and approve the Increase in Authorized Share Capital of the Company.3. To consider and approve the Issue of Bonus Shares.Further, as informed by Company''s vide letter dated March 31, 2022, the trading window has been already closed from April 01, 2022 and shall remain closed till 48 hours from the closure of the Board Meeting.
23-05-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.

 ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve Pursuant to the Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, It is hereby informed you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, 30th May, 2022 at 05:30 P.M. at the Registered Office of the Company situated at Darbara Complex, SCO-113, District Shopping Centre, B Block, Ranjit Avenue, Amritsar-143001, inter alia transact the following business as per enclosed attachment.
21-05-2022
Next Page
Close

Let's Open Free Demat Account